US Stock MarketDetailed Quotes
ALIM Alimera Sciences
- 5.575
- -0.005-0.09%
Trading Jul 17 10:10 ET
292.07MMarket Cap-22300P/E (TTM)
5.580High5.560Low5.78KVolume5.560Open5.580Pre Close32.21KTurnover0.06%Turnover RatioLossP/E (Static)52.39MShares5.65052wk High7.18P/B58.92MFloat Cap2.60652wk Low--Dividend TTM10.57MShs Float190.500Historical High--Div YieldTTM0.36%Amplitude1.300Historical Low5.570Avg Price1Lot Size
Alimera Sciences Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 69.87%23.01M | 49.19%80.75M | 87.51%26.31M | 71.82%23.36M | 20.09%17.54M | 13.85%13.55M | -8.30%54.13M | 0.50%14.03M | 11.89%13.6M | -32.71%14.6M |
| Operating revenue | 69.87%23.01M | 49.19%80.75M | 87.51%26.31M | 71.82%23.36M | 20.09%17.54M | 13.85%13.55M | -8.30%54.13M | 0.50%14.03M | 11.89%13.6M | -32.71%14.6M |
| Cost of revenue | 65.34%3.35M | 35.85%10.84M | 70.64%3.63M | 37.49%2.76M | 11.96%2.43M | 20.71%2.03M | 13.47%7.98M | 8.09%2.13M | 18.77%2.01M | 19.47%2.17M |
| Gross profit | 70.67%19.66M | 51.49%69.92M | 90.52%22.68M | 77.76%20.61M | 21.51%15.11M | 12.72%11.52M | -11.24%46.15M | -0.74%11.9M | 10.78%11.59M | -37.47%12.44M |
| Operating expense | 48.18%21.96M | 24.32%71.85M | 56.69%21.96M | 24.99%18.75M | 13.25%16.32M | 3.17%14.82M | 10.71%57.79M | -4.97%14.01M | 20.16%15M | 11.83%14.41M |
| Selling and administrative expenses | 45.50%14.51M | 19.60%46.48M | 55.48%14.15M | 17.16%11.55M | 10.16%10.81M | -1.17%9.98M | 8.41%38.86M | -12.22%9.1M | 15.15%9.86M | 12.93%9.81M |
| -Selling and marketing expense | 56.48%9.08M | 7.54%27.95M | 34.74%7.77M | 22.08%7.94M | -6.28%6.43M | -15.31%5.8M | 12.65%25.99M | -19.58%5.77M | 13.09%6.5M | 28.78%6.87M |
| -General and administrative expense | 30.23%5.43M | 43.97%18.53M | 91.33%6.38M | 7.61%3.61M | 48.49%4.37M | 28.73%4.17M | 0.76%12.87M | 4.29%3.33M | 19.37%3.35M | -12.25%2.95M |
| Research and development costs | 4.73%4.36M | 2.45%16.63M | 12.74%4.77M | -9.77%4.05M | -7.22%3.65M | 16.22%4.16M | 17.78%16.23M | 13.71%4.23M | 36.76%4.48M | 10.23%3.93M |
| Depreciation amortization depletion | 353.01%3.09M | 223.24%8.75M | 345.10%3.04M | 375.90%3.16M | 178.51%1.87M | -1.16%681K | 4.92%2.71M | 3.64%683K | 2.31%664K | 5.85%670K |
| -Depreciation and amortization | 353.01%3.09M | 223.24%8.75M | 345.10%3.04M | 375.90%3.16M | 178.51%1.87M | -1.16%681K | 4.92%2.71M | 3.64%683K | 2.31%664K | 5.85%670K |
| Operating profit | 30.28%-2.3M | 83.40%-1.93M | 134.35%724K | 154.35%1.85M | 38.80%-1.21M | 20.38%-3.3M | -5,691.04%-11.64M | 23.40%-2.11M | -68.69%-3.41M | -128.19%-1.97M |
| Net non-operating interest income expense | -124.30%-3.74M | -73.18%-10.19M | -190.94%-4.75M | -38.00%-2.07M | -22.49%-1.69M | -22.21%-1.67M | -8.65%-5.88M | -19.88%-1.63M | -10.29%-1.5M | -2.67%-1.38M |
| Non-operating interest expense | 124.30%3.74M | 73.18%10.19M | 190.94%4.75M | 38.00%2.07M | 22.49%1.69M | 22.21%1.67M | 8.65%5.88M | 19.88%1.63M | 10.29%1.5M | 2.67%1.38M |
| Other net income (expense) | -24,300.00%-242K | -1,321.15%-7.93M | 756.41%256K | -224.85%-1.09M | -2,842.08%-7.1M | 100.23%1K | -133.21%-558K | -62.50%-39K | 65.57%-334K | -89.84%259K |
| Gain on sale of security | -24,300.00%-242K | -1,127.78%-6.85M | 756.41%256K | -224.85%-1.09M | -2,425.48%-6.02M | 100.23%1K | -398.21%-558K | -62.50%-39K | 65.57%-334K | -65.79%259K |
| Special income (charges) | ---- | ---1.08M | --0 | --0 | ---1.08M | ---- | --0 | --0 | --0 | --0 |
| -Less:Other special charges | ---- | --1.08M | --0 | ---- | --1.08M | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -26.47%-6.28M | -10.89%-20.05M | 0.19%-3.77M | 75.20%-1.3M | -222.92%-10M | 16.57%-4.97M | -359.56%-18.08M | 8.65%-3.78M | -20.52%-5.25M | -137.76%-3.1M |
| Income tax | -32K | 203.57%85K | 800.00%7K | 341.67%53K | 47.06%25K | 0 | -93.61%28K | 96.97%-1K | 107.10%12K | -97.34%17K |
| Net income | -25.83%-6.25M | -11.18%-20.13M | -0.03%-3.78M | 74.24%-1.35M | -221.96%-10.03M | 16.57%-4.97M | -314.16%-18.11M | 7.94%-3.78M | -25.68%-5.26M | -141.18%-3.12M |
| Net income continuous Operations | -25.83%-6.25M | -11.18%-20.13M | -0.03%-3.78M | 74.24%-1.35M | -221.96%-10.03M | 16.57%-4.97M | -314.16%-18.11M | 7.94%-3.78M | -25.68%-5.26M | -141.18%-3.12M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -25.83%-6.25M | -11.18%-20.13M | -0.03%-3.78M | 74.24%-1.35M | -221.96%-10.03M | 16.57%-4.97M | -314.16%-18.11M | 7.94%-3.78M | -25.68%-5.26M | -141.18%-3.12M |
| Preferred stock dividends | 1.26M | 0 | 576K | 669K | 14K | |||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -25.47%-6.25M | -18.14%-21.39M | -0.03%-3.78M | 63.29%-1.93M | -243.43%-10.7M | 16.34%-4.98M | -314.16%-18.11M | 7.94%-3.78M | -25.68%-5.26M | -144.57%-3.12M |
| Basic earnings per share | 83.10%-0.12 | 67.57%-0.84 | 87.04%-0.07 | 92.00%-0.06 | -193.33%-1.32 | 16.47%-0.71 | -292.42%-2.59 | 8.47%-0.54 | -25.00%-0.75 | -143.69%-0.45 |
| Diluted earnings per share | 83.10%-0.12 | 67.57%-0.84 | 87.04%-0.07 | 92.00%-0.06 | -193.33%-1.32 | 16.47%-0.71 | -292.42%-2.59 | 8.47%-0.54 | -25.00%-0.75 | -143.69%-0.45 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg